DIN reported Q1 2026 results this morning, and for the first time in a while the news was unambiguously better than the Street had prepared for.
Adjusted EPS came in at $1.07, beating the $1.01 consensus. Revenue of $225.2 million also topped estimates of $222.3 million. Basic EPS from continuing operations rose to $0.57, up from $0.53 a year ago. The stock gained 5.5% on the day and is up about 10% over the past month, trading at $28.15. That's context worth holding — shares were briefly halted mid-session pending the news before recovering quickly. The beat matters, but so does what the short interest data says about who was positioned for it.
Short sellers were not positioned for relief. SI is running at nearly 18.8% of the free float, up from roughly 16.4% at the start of April — a gain of around 2.4 percentage points in five weeks. The rise has been nearly continuous, with shares short climbing from about 2.0 million at the end of March to 2.32 million as of Tuesday. Despite today's price pop, nothing in the near-term lending picture suggests the short community was caught off-guard by size; borrowing cost remains modest at 0.82% annualised, barely changed on the week, and the lending pool is far from tight, with availability in a comfortable range. Days to cover of 6.5 according to the most recent FINRA fortnightly report means unwinding would take meaningful time, but there is no immediate squeeze dynamic. The ORTEX short score of 71.0 — its highest reading of the past two weeks — confirms the build is persistent rather than noise.
Options tell a more defensive story than the short book alone. The put/call ratio closed at 1.28 on Tuesday, more than two standard deviations above its 20-day mean of 0.88, and near the top of its 52-week range (high: 1.41). That elevated put demand was set before the earnings print — a clear signal that options traders were bracing for downside rather than positioned for a beat. The combination of high PCR and rising short interest heading into the number makes the earnings-day rally more interesting. Some of that hedging overhang now needs to unwind. Whether it comes off quickly or slowly will say something about how much conviction traders have in the Q1 beat as a turning point.
The Street arrived at earnings with uniformly cautious positioning. All seven covering analysts held a Neutral or equivalent rating heading into today, with no Buy on the board. The mean price target of $30.25 sits modestly above the current $28.15, implying roughly 7.5% upside — a narrow gap that reflects limited conviction in a re-rating. The most recent analyst actions, from early April, were further trimming: Mizuho lowered its target from $34 to $30, while Keybanc stepped down a full notch from Overweight to Sector Weight. Barclays had already cut its target from $40 to $30 back in February, after the Q4 miss. Factor scores reinforce the bearish lean: the EPS surprise rank is near the bottom of the universe at just the 6th percentile, though today's beat could begin to move that metric. The EV/EBITDA multiple of 8.3x has drifted modestly higher over the past month, reflecting the price recovery.
One genuinely interesting footnote on the ownership side is the Independent Chairman's activity. Douglas Pasquale made five separate open-market purchases in early March, accumulating 4,500 shares across price levels ranging from $27.75 to $30. That buying came as the stock was weakening, and the current price of $28.15 puts him roughly at break-even on those trades. The net insider figure for the 90-day window is modestly positive in aggregate, though the CEO sold shares in early March at $31.58 — above current levels — so the picture is mixed rather than a clean bullish signal.
The Q1 beat clears one hurdle. What to watch next is whether the Street upgrades its view — or holds at Neutral while trimming targets further — and whether the unusually elevated put/call ratio normalises as hedges roll off in the coming sessions.
See the live data behind this article on ORTEX.
Open DIN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
